Beyond gene interference approaches such as siRNA or shRNA, pharmacological disruption of the CD47/αvβ3 axis using monoclonal antibodies, peptide inhibitors, or small‐molecule compounds might offer a promising avenue to potentiate macrophage‐driven phagocytosis of malignant cells, thereby advancing strategies aimed at overcoming tumor immune evasion. Here, CD47 is linked to neoplasm.